+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-24Number of Pages: 139

Tissue Engineered Collagen Biomaterials Market (Source - Bovine, Porcine, Marine, and Chicken; Application - Orthopedic and Wound Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Tissue Engineered Collagen Biomaterials Market: Snapshot

Mergers, acquisitions, and distribution agreements are some of the methods leveraged by success-hungry players in the global tissue engineered collagen biomaterials market in order to grow their shares. One of the prominent manufacturers Medtronic, for instance, acquired Covidien, a global healthcare products company, in January 2016 to gain greater stronghold in the global medical device industry.

The global tissue engineered collagen biomaterials market has been majorly fuelled by the extensive research and development activities in regenerative medicine and rising use of collagen as bone substitutes. Another growth driver in the market is the use of collagen in wound healing which offers numerous benefits in terms of stimulating tissue growth and ensuring relief for a variety of injuries on bones and tissues.

On the flipside, however, non-rigidity, potential for antigenicity through telopeptides and collagen materials have the potential to cause cell behavior alteration. This is serving to act as a deterrent to the global tissue engineered collagen biomaterials market. In addition, the transmission of lethal diseases such as mad-cow disease and bird flu, and growing number of government regulations for quality assurance of animal derived products are also negatively impacting the market.

A report by Transparency Market Research forecasts the global tissue engineered collagen biomaterial market to rise at a solid CAGR of 10.4% from 2017 to 2025 to become worth US$5.4 bn in 2025 from US$ 2.2 bn in 2016.

 

tissue engineered collagen biomaterials market

 

Wound Care Application Segment to Rise at Maximum Pace Owing to Rising Burn Injuries in U.S.

The global tissue engineered collagen biomaterial market can be segmented depending upon application into orthopedics and wound care, among others. The orthopedics segment, at present, leads with maximum market share due to the numerous applications in bone, tendon, and ligament injuries of collagen. As per a report by the National Osteoporosis Foundation in 2014, about 54 million people over 50 years of age in the U.S. are affected by low bone mass and osteoporosis and this has helped catalyze growth in the market.

The wound care segment trails the orthopedics segment in terms of market share and going forward, is expected to register a strong growth pace. According to the American Burn Association (ABA), about a million burn injuries occurs annually in the U.S. and nearly 4,500 patient succumb to it.

Burgeoning Geriatric Population Propels Growth in Asia Pacific Market

Geographically, North America is a market leader that is expected to retain its dominant position in the years ahead as well. A solid manufacturing infrastructure, increasing collagen applications across various industries, and growing thrust on research to develop unique solutions for tissue engineering leading to emergence of many collagen-based products, will likely boost growth in the market. The North America market is slated to become worth US$17 bn by 2025 by clocking a CAGR of 10.0%.

In terms of growth rate, however, Asia Pacific is anticipated to outshine all other regions by registering a solid CAGR of 11.1% from 2017 to 2025. A burgeoning geriatric population and the increasing instances of chronic diseases are said to be driving growth in the region. Growing uptake of advanced wound care products by healthcare professionals and favorable government reimbursement policies are also serving to bolster the tissue engineered collagen biomaterials market in Asia Pacific.

Some of the prominent participants operating in the global tissue engineered collagen biomaterials market are Collagen Matrix Inc., Medtronic, Advanced BioMatrix Inc., Kyeron B.V., Collagen Matrix, Collagen Solutions Plc., CollPlant Ltd., Fraunhofer-Gesellschaft, GENOSS Co., Ltd., and Maxigen Biotech Inc.

1 Preface
    1.1 Market Definition and Scope
    1.2 Market Segmentation    
    1.3 Key Research Objectives    
    1.4 Research Highlights

2 Assumptions and Research Methodology

3 Executive Summary: Global Tissue Engineered Collagen Biomaterials Market

4 Market Overview
    4.1 Introduction
          4.1.1 Product Overview
          4.1.2 Industry Evolution / Developments
          4.1.3 Key Market Indicators
    4.2 Market Dynamics 
          4.2.1 Drivers
          4.2.2 Restraints
          4.2.3 Opportunity
    4.3 Market Revenue Projections    
    4.4 Porter’s Five Force Analysis    
    4.5 Value Chain Analysis
    4.6 Market Outlook

5 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Source
    5.1 Key Findings / Developments
    5.2 Introduction & Definition
    5.3 Market Value Forecast by Source, 2017–2025
          5.3.1 Bovine
          5.3.2 Porcine
          5.3.3 Marine
          5.3.4 Chicken
          5.3.5 Others
    5.4 Key Trends
    5.5 Market Attractiveness by Source

6 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Application
    6.1 Key Findings / Developments
    6.2 Introduction & Definition
    6.3 Market Value Forecast by Application, 2017–2025
          6.3.1 Orthopedic
          6.3.2 Wound Care
          6.3.3 Others
    6.4 Key Trends
    6.5 Market Attractiveness by Application

7 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Region
    7.1 Global Tissue Engineered Collagen Biomaterial Market Snapshot, by Country
    7.2 Introduction
    7.3 Global Tissue Engineered Collagen Biomaterial Market Forecast By Region
    7.4 Global Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, By Region
    7.5 Key Insights

8 North America Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
    8.1 North America Market Value Share Analysis, By Country
    8.2 North America Market Forecast By Country    
    8.3 North America Market Forecast By Source
    8.4 North America Market Forecast By Application
    8.5 North America Market Attractiveness Analysis

9 Europe Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
    9.1 Europe Market Value Share Analysis, By Country
    9.2 Europe Market Forecast By Country
    9.3 Europe Market Forecast By Source
    9.4 Europe Market Forecast By Application    
    9.5 Europe Market Attractiveness Analysis

10 Asia Pacific Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts    
    10.1 Asia Pacific Market Value Share Analysis, By Country
    10.2 Asia Pacific Market Forecast By Country
    10.3 Asia Pacific Market Forecast By Source
    10.4 Asia Pacific Market Forecast By Application
    10.5 Asia Pacfic Market Attractiveness Analysis

11 Latin America Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
    11.1 Latin America Market Value Share Analysis, By Country
    11.2 Latin America Market Forecast By Country
    11.3 Latin America Market Forecast By Source
    11.4 Latin America Market Forecast By Application
    11.5 Latin America Market Attractiveness Analysis

12 Middle East & Africa (MEA) Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
    12.1 MEA Value Share Analysis, By Country
    12.2 MEA Market Forecast By Country
    12.3 MEA Market Forecast By Source
    12.4 MEA Market Forecast By Application
    12.5 MEA Market Attractiveness Analysis

13 Competitive Landscape
    13.1 Competition Matrix
    13.2 Tissue Engineered Collagen Biomaterials Market: Heat Map Analysis By Company     
    13.3 Company Profiles 
          13.3.1 Advanced BioMatrix Inc.
                   13.3.1.1 Company Details
                   13.3.1.2 Company Description
                   13.3.1.3 Business Overview
                   13.3.1.4 SWOT Analysis
                   13.3.1.5 Financial Analysis
                   13.3.1.6 Strategic Overview
          13.3.2  Collagen Matrix Inc.
                   13.3.2.1 Company Details
                   13.3.2.2 Company Description
                   13.3.2.3 Business Overview
                   13.3.2.4 SWOT Analysis
                   13.3.2.5 Financial Analysis
                   13.3.2.6 Strategic Overview
          13.3.3  CollPlant Ltd.
                   13.3.3.1 Company Details
                   13.3.3.2 Company Description
                   13.3.3.3 Business Overview
                   13.3.3.4 SWOT Analysis
                   13.3.3.5 Financial Analysis
                   13.3.3.6 Strategic Overview
          13.3.4  Collagen Matrix
                   13.3.4.1 Company Details
                   13.3.4.2 Company Description
                   13.3.4.3 Business Overview
                   13.3.4.4 SWOT Analysis
                   13.3.4.5 Financial Analysis
                   13.3.4.6 Strategic Overview
          13.3.5  Collagen Solutions Plc.       
                   13.3.5.1 Company Details
                   13.3.5.2 Company Description
                   13.3.5.3 Business Overview
                   13.3.5.4 SWOT Analysis
                   13.3.5.5 Financial Analysis
                   13.3.5.6 Strategic Overview
          13.3.6  Fraunhofer-Gesellschaft
                   13.3.6.1 Company Details
                   13.3.6.2 Company Description
                   13.3.6.3 Business Overview
                   13.3.6.4 SWOT Analysis
                   13.3.6.5 Financial Analysis
                   13.3.6.6 Strategic Overview
          13.3.7  GENOSS Co., Ltd.
                   13.3.7.1 Company Details
                   13.3.7.2 Company Description
                   13.3.7.3 Business Overview
                   13.3.7.4 SWOT Analysis
                   13.3.7.5 Financial Analysis
                   13.3.7.6 Strategic Overview
          13.3.8  Kyeron B.V.
                   13.3.8.1 Company Details
                   13.3.8.2 Company Description
                   13.3.8.3 Business Overview
                   13.3.8.4 SWOT Analysis
                   13.3.8.5 Financial Analysis
                   13.3.8.6 Strategic Overview
          13.3.9  Maxigen Biotech Inc.
                   13.3.9.1 Company Details
                   13.3.9.2 Company Description
                   13.3.9.3 Business Overview
                   13.3.9.4 SWOT Analysis
                   13.3.9.5 Financial Analysis
                   13.3.9.6 Strategic Overview
          13.3.10 Medtronic
                   13.3.10.1 Company Details
                   13.3.10.2 Company Description
                   13.3.10.3 Business Overview
                   13.3.10.4 SWOT Analysis
                   13.3.10.5 Financial Analysis
                   13.3.10.6 Strategic Overview

List of Figures

Figure 1: Global Tissue Engineered Collagen Biomaterials Market Size, by Sources (US$ Mn), 2016
Figure 2: Global Tissue Engineered Collagen Biomaterials  Market Value (US$ Mn), 2016
Figure 3: Revenue Share, 2016
Figure 4: Key Industry Events
Figure 5: Tissue Engineered Collagen Biomaterials Market: Porter’s Five Force Analysis
Figure 6: Value Chain Analysis: Global Tissue Engineered Collagen Biomaterial Market 
Figure 7: Global Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, 2015–2025
Figure 8: Market Value Share, by Source (2016)
Figure 9: Market Value Share, by Application (2016)
Figure 10: Market Value Share, by Region (2016)
Figure 11: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Sources, 2017 and 2025
Figure 12: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Sources, 2017–2025
Figure 13: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Marine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Bovine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Porcine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Chicken, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Other Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Applications, 2017 and 2025
Figure 19: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Applications, 2017–2025
Figure 20: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Applications Wound Care, Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 21: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Applications Orthopedics, Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 22: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Other Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 23: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Region, 2017 and 2025
Figure 24: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Region, 2017–2025
Figure 25: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and2025
Figure 26: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 27: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 28: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 29: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 30: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017–2025
Figure 31: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 32: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 33: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 34: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 35: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 36: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 37: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 38: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 39: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 40: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 41: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 42: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 43: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 44: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 45: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 46: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 47: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 48: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 49: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 50: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 51: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 52: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 53: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 54: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 55: Tissue Engineered Collagen Biomaterials Market: Heat Map Analysis by Company (2016)
Figure 56: Collagen Solution plc, Breakdown of Net Sales, by Region, 2016
Figure 57: Collagen Solution plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 58: CollPlant Ltd., Product Development Events and recognition
Figure 59: CollPlant Ltd., Management List
Figure 60: Medtronic, Breakdown of Net Sales, by Region, 2016
Figure 61: Medtronic, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 62: Advanced BioMatrix, Inc., Distributors geographical presence
Figure 63: Advanced BioMatrix, Inc., Core Capabilities
Figure 64: Olympus Terumo Biomaterials Corp, Breakdown of Net Sales, by Region, 2016
Figure 65: Olympus Terumo Biomaterials Corp, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Fraunhofer-Gesellschaft, Subsidiaries are Present in the Following Countries
Figure 67: Fraunhofer-Gesellschaft, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Collagen Matrix Inc., Adopted technology for Collagen Formation
Figure 69: Collagen Matrix Inc., Key Management
Figure 70: KYERON, Recent Achievements
Figure 71: KYERON, Recent Approvals

List of Tables

Table 1: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Sources, 2015–2025
Table 2: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Applications, 2015–2025
Table 3: Global Tissue Engineered Collagen Biomaterials Market Volume (Million Units) Forecast, by Applications, 2015–2025
Table 4: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 5: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 6: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 7: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 8: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 9: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 10: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 11: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 13: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 14: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 16: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 17: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 19: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025

Global Tissue Engineered Collagen Biomaterials Market: Overview

This report provides in-depth region wise and country wise analysis of the tissue engineered collagen biomaterials market. Stakeholders of this report include manufacturers of tissue engineered collagen biomaterials, raw material suppliers, research institutes involve in the research of tissue engineered collagen and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global tissue engineered collagen biomaterials market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global tissue engineered collagen biomaterials market in major countries globally such as the U.S., Canada, Germany, Italy, France, United Kingdom, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the tissue engineered collagen biomaterials with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global tissue engineered collagen biomaterials market. These factors would aid the stakeholders in establishing a strong foothold in the global tissue engineered collagen biomaterials market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the tissue engineered collagen biomaterials market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Tissue Engineered Collagen Biomaterials Market: Segmentation

The tissue engineered collagen biomaterials market has been segmented as by source, by application and by geography. Based on source the market has been segmented into bovine, porcine, marine, chicken and others. Based on application the market has been segmented into orthopedic, wound care and others.

Geographically, the tissue engineered collagen biomaterials market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, Italy, France, U.K., Spain, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the tissue engineered collagen biomaterials market in various regions has been provided in this section.

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.

Global Tissue Engineered Collagen Biomaterials Market: Competitive Analysis

The report provides a detailed outline/blueprint of the tissue engineered collagen biomaterials market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Advanced BioMatrix Inc., Collagen Matrix Inc., CollPlant Ltd., Collagen Matrix, Collagen Solutions Plc., Fraunhofer-Gesellschaft, GENOSS Co., Ltd., Kyeron B.V., Maxigen Biotech Inc., and Medtronic.

The global tissue engineered collagen biomaterials market has been segmented into:

  • Global Tissue Engineered Collagen Biomaterials Market, by Source
    • Bovine
    • Porcine
    • Marine
    • Chicken
    • Others
       
  • Global Tissue Engineered Collagen Biomaterials Market, by Application
    • Orthopedic
    • Wound Care
    • Others
       
  • Global Tissue Engineered Collagen Biomaterials Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of APAC
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa (MEA)
      • Saudi Arabia
      • South Africa
      • Rest of MEA


 
 
Back To Top